Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
eREX, Oct-Dec (3Q) Net Income Turns to Profit, The Undetermined Dividend Set at 11 yen, Resuming Dividends for the First Time in Two Terms
9517 eREX Co.,Ltd. 【J-GAAP】
Earnings ReporteREX Co.,Ltd. <9517> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 12th (15:30). The consolidated net income/loss for the cumulative third quarter of the fiscal year ending March 2025 (April to December) turned into a profit of 4.41 billion yen (compared to a loss of 15.2 billion yen in the same period last year). The progress rate toward the full-year plan of 1.88 billion yen is 234.3%.
At the same time, the company has decided to implement a year-end lump-sum dividend of 11 yen for the current fiscal year, which was previously undecided, reinstating dividends for the first time in two terms.
In the most recent three-month period, from October to December (3Q), the consolidated net income/loss turned to a profit of 2.72 billion yen (compared to a loss of 4.56 billion yen in the same period last year). The operating profit/loss margin drastically improved from -7.1% in the same period last year to 6.6%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 221,711 | 14,316 | 11,119 | 5,903 | 99.8 | 73.0 | Feb 10, 2023 | J-GAAP |
Apr - Dec, 2023 | 184,305 | -14,205 | -13,175 | -15,204 | -256.4 | ー | Feb 9, 2024 | IFRS |
Apr - Dec, 2024 | 126,583 | 8,008 | 8,322 | 4,416 | 60.8 | 189.7 | Feb 12, 2025 | IFRS |
YoY | -31.3% | - | - | - | - |
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 72,242 | 234 | 37 | 198 | 2.5 | - | Nov 8, 2024 | IFRS |
Oct - Mar, 2024 New | 72,242 | 234 | 37 | 198 | 2.5 | 11 | Feb 12, 2025 | IFRS |
Revision Rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 155,456 | 5,378 | 4,388 | 1,885 | 24.2 | - | May 10, 2024 | IFRS |
Mar, 2025 New | 155,456 | 5,378 | 4,388 | 1,885 | 24.2 | 11 | Feb 12, 2025 | IFRS |
Revision Rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 124,083 | -10,125 | -9,704 | -11,621 | -196.0 | 0 | May 10, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 72,242 | 234 | 37 | 198 | 2.5 | 11 | Feb 12, 2025 | IFRS |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 296,312 | 14,823 | 15,234 | 9,131 | 154.3 | 22 | May 12, 2023 | J-GAAP |
Mar, 2024 | 244,977 | -19,851 | -18,388 | -22,257 | -375.3 | 0 | May 10, 2024 | J-GAAP |
Mar, 2025 Guidance | 155,456 | 5,378 | 4,388 | 1,885 | 24.2 | 11 | Feb 12, 2025 | IFRS |
YoY | - | - | - | - | - |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 63,411 | -4,479 | -4,491 | -4,568 | -77.1 | -7.1 | Feb 9, 2024 | IFRS |
Jan - Mar, 2024 | 60,672 | -4,698 | -4,531 | -6,370 | -107.4 | -7.7 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 33,440 | 1,911 | 3,143 | 1,747 | 25.2 | 5.7 | Aug 9, 2024 | IFRS |
Jul - Sep, 2024 | 49,774 | 3,233 | 1,208 | -60 | -0.8 | 6.5 | Nov 8, 2024 | IFRS |
Oct - Dec, 2024 | 43,369 | 2,864 | 3,971 | 2,729 | 37.6 | 6.6 | Feb 12, 2025 | IFRS |
YoY | -31.6% | - | - | - | - |
Related Articles
GMO Payment Gateway, Oct-Dec (1Q) Net Income Increases by 32%
GMO Financial Gate, Oct-Dec (1Q) Net Income Increases by 90%
JSH, The Current Fiscal Year Ordinary Profit Revised Downward by 4%
PCI Holdings, Oct-Dec (1Q) Ordinary Profit Increases by 67%
Japan Display, The Current Fiscal Year Net Income Loss Widened in Downward Revision, 72% Deficit Against Net Assets
Photosynth, 76% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
I-ne, 8% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term, Dividend Raised by 0.5 yen
Recovery International, 1% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term
FUSO DENTSU, Oct-Dec (1Q) Ordinary Profit Decreases by 6%
C.I. MEDICAL, 63% Increase in Ordinary Profit for The Current Fiscal Year